Mankind Pharma Limited has informed the Exchange about Incorporation
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has formally incorporated a wholly owned subsidiary in Russia named 'Mankind Pharma LLC' on August 18, 2025. This is an update to an earlier disclosure from April 14, 2025, where the company had first announced its plan to set up this overseas entity. The subsidiary has been registered under Russian law, marking the actual completion of the proposed structure. No financial details such as capital infusion or business scope have been shared in this particular filing, as those were covered in the April 14 communication. The move is part of the company's broader international expansion plans.
For shareholders, this is a procedural update confirming the Russia subsidiary is now operational. It signals continued overseas growth ambitions but is unlikely to cause an immediate stock price reaction since the plan was already disclosed months ago.